Compounds > 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone
Page last updated: 2024-11-03

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Colitis

4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone has been researched along with Colitis in 1 studies

4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone: Inhibitor of phosphodiesterases.

Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lamrani, A1
Tulliez, M1
Chauvelot-Moachon, L1
Chaussade, S1
Mauprivez, C1
Hagnéré, AM1
Vidon, N1

Other Studies

1 other study available for 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone and Colitis

ArticleYear
Effects of octreotide treatment on early TNF-alpha production and localization in experimental chronic colitis.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:5

    Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Animals; Anti-Inflammatory Agents; Chronic Disease;

1999